AUB ScholarWorks

Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon

Show simple item record

dc.contributor.author Matar G.M.
dc.contributor.author Cuzon G.
dc.contributor.author Araj G.F.
dc.contributor.author Naas T.
dc.contributor.author Corkill J.
dc.contributor.author Kattar M.M.
dc.contributor.author Nordmann P.
dc.contributor.editor
dc.date Aug-2008
dc.date.accessioned 2017-10-05T15:35:29Z
dc.date.available 2017-10-05T15:35:29Z
dc.date.issued 2008
dc.identifier 10.1111/j.1469-0691.2008.02059.x
dc.identifier.isbn
dc.identifier.issn 1198743X
dc.identifier.uri http://hdl.handle.net/10938/15513
dc.description.abstract [No abstract available]
dc.format.extent
dc.format.extent Pages: (887-888)
dc.language English
dc.publisher MALDEN
dc.relation.ispartof Publication Name: Clinical Microbiology and Infection; Publication Year: 2008; Volume: 14; no. 9; Pages: (887-888);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon
dc.type Letter
dc.contributor.affiliation Matar, G.M., American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Cuzon, G., INSERM U914 Université Paris Sud, Paris, France
dc.contributor.affiliation Araj, G.F., American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Naas, T., INSERM U914 Université Paris Sud, Paris, France
dc.contributor.affiliation Corkill, J., University of Liverpool, Liverpool, United Kingdom
dc.contributor.affiliation Kattar, M.M., American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Nordmann, P., INSERM U914 Université Paris Sud, Paris, France
dc.contributor.authorAddress Matar, G.M.; American University of Beirut, Beirut, Lebanon; email: gmatar@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Experimental Pathology, Immunology and Microbiology;
dc.contributor.authorDepartment Experimental Pathology, Immunology and Microbiology
dc.contributor.authorDivision
dc.contributor.authorEmail gmatar@aub.edu.lb
dc.contributor.Faculty Faculty of Medicine
dc.contributor.authorInitials Matar, GM
dc.contributor.authorInitials Cuzon, G
dc.contributor.authorInitials Araj, GF
dc.contributor.authorInitials Naas, T
dc.contributor.authorInitials Corkill, J
dc.contributor.authorInitials Kattar, MM
dc.contributor.authorInitials Nordmann, P
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Matar, GM (reprint author), Amer Univ Beirut, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Aktas Z, 2008, CHEMOTHERAPY, V54, P101, DOI 10.1159-000118661; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI S; CUZON G, 2007, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128-AAC.01180-07; Deshpande LM, 2006, MICROB DRUG RESIST, V12, P223, DOI 10.1089-mdr.2006.12.223; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016-j.ijantimicag.2008.01.017; Kanj SS, 2008, CLIN MICROBIOL INFEC, V14, P501, DOI 10.1111-j.1469-0691.2008.01964.x; Leavitt A, 2007, ANTIMICROB AGENTS CH, V51, P3026, DOI 10.1128-AAC.00299-07; Naas T, 2003, ANTIMICROB AGENTS CH, V47, P19, DOI 10.1128-AAC.47.1.19-26.2003; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128-AAC.00438-06; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128-AAC.48.1.15-22.2004; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217-17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128-CMR.00001-07
dc.description.citedCount 19
dc.description.citedTotWOSCount 18
dc.description.citedWOSCount 18
dc.format.extentCount 2
dc.identifier.articleNo
dc.identifier.coden CMINF
dc.identifier.pubmedID 18844693
dc.identifier.scopusID 50149087907
dc.identifier.url
dc.publisher.address COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Clin. Microbiol. Infect.
dc.relation.ispartOfIssue 9
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Clinical Microbiology and Infection
dc.relation.ispartofPubTitleAbbr Clin. Microbiol. Infect.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 14
dc.source.ID WOS:000258441400013
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7
dc.subject.otherChemCAS beta lactamase, 9073-60-3
dc.subject.otherChemCAS cefalotin, 153-61-7, 58-71-9
dc.subject.otherChemCAS cefepime, 88040-23-7
dc.subject.otherChemCAS cefixime, 79350-37-1
dc.subject.otherChemCAS cefotaxime, 63527-52-6, 64485-93-4
dc.subject.otherChemCAS ceftazidime, 72558-82-8
dc.subject.otherChemCAS clavulanic acid, 58001-44-8
dc.subject.otherChemCAS cotrimoxazole, 8064-90-2
dc.subject.otherChemCAS ertapenem, 153773-82-1, 153832-38-3, 153832-46-3
dc.subject.otherChemCAS imipenem, 64221-86-9
dc.subject.otherChemCAS piperacillin, 59703-84-3, 61477-96-1
dc.subject.otherChemCAS tazobactam, 93528-38-2
dc.subject.otherChemCAS ticarcillin, 29457-07-6, 34787-01-4, 4697-14-7
dc.subject.otherChemCAS tigecycline, 220620-09-7
dc.subject.otherChemCAS Anti-Bacterial Agents
dc.subject.otherChemCAS Carbapenems
dc.subject.otherIndex aminoglycoside antibiotic agent
dc.subject.otherIndex amoxicillin
dc.subject.otherIndex bacterial enzyme
dc.subject.otherIndex beta lactamase
dc.subject.otherIndex beta lactamase OXA 48
dc.subject.otherIndex carbapenem derivative
dc.subject.otherIndex cefalotin
dc.subject.otherIndex cefepime
dc.subject.otherIndex cefixime
dc.subject.otherIndex cefotaxime
dc.subject.otherIndex ceftazidime
dc.subject.otherIndex clavulanic acid
dc.subject.otherIndex cotrimoxazole
dc.subject.otherIndex ertapenem
dc.subject.otherIndex imipenem
dc.subject.otherIndex oxacillinase
dc.subject.otherIndex piperacillin
dc.subject.otherIndex quinoline derived antiinfective agent
dc.subject.otherIndex tazobactam
dc.subject.otherIndex ticarcillin
dc.subject.otherIndex tigecycline
dc.subject.otherIndex antibiotic resistance
dc.subject.otherIndex bacterial gene
dc.subject.otherIndex case report
dc.subject.otherIndex controlled study
dc.subject.otherIndex Escherichia coli
dc.subject.otherIndex female
dc.subject.otherIndex gene sequence
dc.subject.otherIndex human
dc.subject.otherIndex Klebsiella pneumoniae
dc.subject.otherIndex Lebanon
dc.subject.otherIndex letter
dc.subject.otherIndex minimum inhibitory concentration
dc.subject.otherIndex nonhuman
dc.subject.otherIndex polymerase chain reaction
dc.subject.otherIndex priority journal
dc.subject.otherIndex school child
dc.subject.otherIndex urinary tract infection
dc.subject.otherIndex Anti-Bacterial Agents
dc.subject.otherIndex beta-Lactam Resistance
dc.subject.otherIndex Carbapenems
dc.subject.otherIndex Child
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Klebsiella Infections
dc.subject.otherIndex Klebsiella pneumoniae
dc.subject.otherIndex Lebanon
dc.subject.otherIndex Microbial Sensitivity Tests
dc.subject.otherIndex Klebsiella pneumoniae
dc.subject.otherKeywordPlus ESCHERICHIA-COLI
dc.subject.otherKeywordPlus EMERGENCE
dc.subject.otherKeywordPlus IMIPENEM
dc.subject.otherKeywordPlus TURKEY
dc.subject.otherKeywordPlus KPC-2
dc.subject.otherWOS Infectious Diseases
dc.subject.otherWOS Microbiology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account